He is a professor of Neurology, Psychiatry, Neuroscience, Psychology, Nursing, Organizational Behavior, Biomedical ethics and History at Case Western Reserve University. He is also chairman of board of the world's first intergenerational, public community school.

Dr. Whitehouse is the author of over 250 scholarly articles as well as the editor of a number of books relating the aging and neuroscience, Gilmore GC, Wykle M, and Whitehouse PJ: Memory, Aging, and Dementia: Theory, Assessment, and Treatment. Springer Verlag, New York, 1989; Binstock R, Post SG, Whitehouse PJ (eds). Dementia and Aging: Ethics, Values and Policy Choices. Johns Hopkins University Press, Baltimore, 1992; Whitehouse PJ (ed): Dementia. FA Davis, Philadelphia, 1993; Post, S., Whitehouse, P.J.[Editors]. Genetic testing for Alzheimer’s disease: Ethical and clinical issues. Baltimore, MD: Johns Hopkins Press, 1998; Whitehouse, P.J., Maurer, K., Ballenger, J. [Editors]. Concepts of Alzheimer disease: Biological, Clinical, and Cultural Perspectives. John Hopkins Press, Baltimore, MD, 2000.

After graduating from Brown University and obtaining a M.D.- Ph.D. from The Johns Hopkins University he completed his medical training in neurology and a fellowship in neuroscience and psychiatry at Johns Hopkins. He served on the faculty for five years before moving to Cleveland, Ohio to found the University Alzheimer Center (now the University Memory and Aging Center) at Case Western Reserve University. He served at the director the center for ten years until he stepped down to direct Integrative Studies. He is also a founder (along with his wife and others) of a unique and innovative multi-age community public school. The Intergenerational School is located at Fairhill Center in Cleveland and serves sixty K-4 children and other learners of all ages committed to value-based, community-oriented, and environmentally conscious real life learning. Dr. Whitehouse has served on numerous local, national and international advisory boards concerning age-related cognitive changes.

His pioneering research at Johns Hopkins identified one of the pathological substrates for the memory and attention problems found in aging and Alzheimer's disease. His discoveries contributed to the development of the first four medications approved the treat this condition. He continues his efforts through the International Working Group for the Harmonization of Dementia Drug Guidelines, which he founded. He has served as a consultant to a variety of multinational pharmaceutical companies, the Food and Drug Administration, and the World Health Organization on the topic of developing more effective treatments for Alzheimer's disease and related conditions.

He is a member of and leader in numerous professional organizations including, American Academy of Neurology, including being a founder of the Section on Geriatric Neurology; American Association for the Advancement of Science; American College of Neuropsychopharmacology; Gerontological Society of America; American Neurological Association; International Psychogeriatric Association; International Association of Gerontology North American Advisory Committee; Society for Neuroscience; American Geriatrics Society (board member) and Foundation for Health in Aging (board member); Chairman, Dementia Research Section of the World Federation of Neurology; Chair of the Global Bioethics Group of the American Society for Bioethics and Humanities; Institute for the Study of Aging Scientific Advisory Board; International Longevity Center Advisory Board.

Dr. Whitehouse is known for his abilities to bridge a variety of topics relating to aging and the brain, including basic neuroscience to clinical care, particularly ethics and drug development, as well as health care and educational systems. In his speaking engagements, he uses multimedia presentations and engages the audience with a high degree of interactivity.

Alzheimer's Disease, Management, Mental Health, Mentoring, Internet, Leadership, Computer Science, Technology,